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Abstract 
Purpose: To assess the perceptions and knowledge of pharmacovigilance and adverse drug reactions 
(ADRs) reporting among Bachelor of Pharmacy (BPharm) and Doctor of Pharmacy (PharmD) students 
of selected tertiary institutions in Jordan. 
Methods: A cross-sectional study involving 434 pharmacy students from three different Jordanian 
universities was conducted from March - April 2014. During the study period, a validated structured 
questionnaire was administered to the participants to assess their knowledge and perceptions regarding 
pharmacovigilance and ADRs reporting process.  
Results: Majority of the students had insufficient awareness and lack of knowledge of 
pharmacovigilance and ADRs reporting with a mean knowledge score of 4/10. PharmD students had 
better knowledge about pharmacovigilance and ADRs reporting system than the BPharm students 
(knowledge score of 5.4 versus 3.2, respectively; p < 0.001). Also, higher knowledge scores were 
recorded for public university and fifth-year students (p < 0.001). About two-thirds of the students 
expressed a positive attitude toward pharmacovigilance and ADRs issues and agreed that they would 
be willing to report ADRs during their clerkship programme.  
Conclusion: BPharm and PharmD students have insufficient knowledge of the concept of 
pharmacovigilance and ADRs reporting. There is a need to incorporate pharmacovigilance into 
pharmacy curriculum in order to increase its awareness among pharmacy students as this will positively 
impact on their practice and enhance public health.  
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The use of medicine is usually associated with 
harm that may range from mild to fatal adverse 
drug reactions (ADRs). About 5 to 20 % of 
hospital admissions are due to ADRs [1,2]. Fatal 
ADRs have been estimated to be a major cause 
of patient-related morbidity and mortality [3]. 
Accordingly, reporting of ADRs is considered to 
be crucial to maintain and achieve safe drug 
therapy in clinical practice [4].  
 
Pharmacists as health care professionals 
working in a hospital or community pharmacy 
can play an essential role in both 
pharmacovigilance activities and ADRs reporting 
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[5], since they may be the first to be contacted by 
patients for information about ADRs [6] and have 
access to the information required to recognise 
and report ADRs [7,8]. Pharmacists are drug 
specialists who have the skills to avoid, identify, 
and resolve treatment-related problems and 
educate patients about their drug therapy [9]. 
However, there is a lack in the pharmacist's 
awareness or knowledge about the guidelines for 
assessing ADRs used by the drug regulatory 
bodies in their countries [10,11]. In addition, 
under-reporting of ADRs is the main inherent 
problem, in which reporting of serious ADRs is 
usually less than 10 % [4,7,12]. 
 
Elsewhere, the involvement of pharmacy 
students in pharmacovigilance and ADRs 
reporting has significantly increased the number 
of documented ADRs [13]. Thus, pharmacy 
students as future pharmacy experts need to be 
well trained on how to identify prevent and report 
ADRs [14]. 
 
Jordan established its own pharmacovigilance 
centre in January 2001. At present, only one 
study has assessed pharmacists’ knowledge and 
attitudes toward ADRs reporting in hospital and 
community settings in Jordan [4]. In the study, 
pharmacists had positive attitudes toward 
pharmacovigilance despite their little experience 
with ADRs reporting and inadequate knowledge 
of the concept of pharmacovigilance [4]. The aim 
of this study, therefore, was to assess the 
perception and knowledge of pharmacy students 
of public and private universities in Jordan of 




Study sites, design and participants 
 
This was a cross-sectional study that involved 
Bachelor of Pharmacy (BPharm) and Doctor of 
Pharmacy (PharmD) students from three 
different Jordanian universities (one public and 
two private universities) in their last two years of 
study (fourth and fifth year for BPharm students 
and fifth and sixth year for PharmD students). 
The universities are located in two of the largest 
cities in Jordan; Amman and Zarqa. The study 
commenced in March 2014 and continued for 
two months. 
 
A total of 630 questionnaires were distributed by 
the investigators to students. The questionnaires 
were handed to students at the beginning of 
different classes after obtaining the instructors’ 
permission. The 434 completed questionnaires 
were returned at the end of the class with a 




A questionnaire previously developed by our 
team was used in this survey [4]. The 
questionnaire included demographic data and 
was structured in two main sections which 
displayed the Knowledge and perceptions of 
students regarding pharmacovigilance and ADRs 
reporting process.  
 
Demographic data included age, gender, type of 
study either pharmacy student or pharmD 
student, if they received any pharmacovigilance 
courses, name of university and year of study. 
Knowledge section included 10 questions to 
assess students’ knowledge regarding the 
definition of pharmacovigilance and adverse drug 
reaction, and their knowledge about the reporting 
process in Jordan. For each correct answer the 
student was assigned a score of 1, and a final 
score out of 10 was calculated for each student 
to assess their knowledge level. So the 
knowledge score ranges from 10 (maximum 
score) to zero (lowest score).  
 
The second section considered students’ beliefs 
and perception, in which they were asked about 
their perceptions regarding the health care 
providers’ responsibilities in reporting ADRs, why 
it is necessary to report ADRs and whether 
pharmacovigilance should be included as a core 




Data were analyzed using statistical package for 
social science version 19 (SPSS, Inc., Chicago, 
IL, USA). Students’ answers were analyzed 
using a 5 - point Likert-type scale consisting of 
‘’strongly agree’’, ‘’agree’’, “uncertain”, 
‘’disagree’’, strongly disagree’’ and uncertain. 
 
Descriptive analysis was done using mean and 
SD for continuous variables and percentage for 
qualitative variables. Independent sample t-test 
and one-way ANOVA were used to evaluate 
differences between groups for continuous 
variables, while Chi-square test was used for 





Demographic characteristics of study sample 
 
The demographic details of the students included 
in the study are shown in Table 1. The mean age 
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of the students were approximately 22.4 ± (1.37) 
years. In this study, 274 (63.1 %) students were 
BPharm while 160 (36.9 %) were PharmD. 
Females accounted for 84.6 % (367) of the 
students. 
 
Students’ knowledge regarding 
pharmacovigilance and ADR reporting 
 
The mean knowledge score of 
pharmacovigilance and ADR reporting for the 
overall study sample was 4.0 (SD = 2.2) with a 
range from zero to 9. 
 
Some of the students (106, 24.4%) defined 
‘pharmacovigilance’ correctly while 62.4 % (n = 
271) defined ADR correctly. More than 50 % of 
students were not aware of the presence of 
pharmacovigilance center in Jordan and they 
were not aware about the official standardized 
form for reporting ADRs and about the reporting 
process (Table 2). 
 
Factors affecting knowledge score among 
Bpharm and PharmD students were assessed 
(Table 3). PharmD students showed a 
significantly better knowledge of 
pharmacovigilance and ADRs reporting system 
than BPharm students (mean score 5.4, 3.2 
respectively; p < 0.001). Also higher knowledge 
score was obtained among students from public 
university and fifth year students. There was no 
significant gender related difference in the 
students’ mean score (p = 0.878). 
 
Beliefs and perception of students towards 
ADRs reporting 
 
Ninety five percent (n= 413) of the students 
believed that pharmacists have an important role 
in ADRs reporting process. The responsibility 
order was as follows: pharmacists (95.3 %, n = 
513), physicians (94.1 %, n = 408), drug 
companies (83.8 %, n = 364), patients (64.5 %, n 
= 280) and nurses (59.9 %, n = 258).  
 
Responses to questions exploring the students’ 
perceptions about pharmacovigilance and ADR 
reporting are shown in Table 4. Nearly 84.9 % (n 
= 360) of the students agreed that 
pharmacovigilance should be included as a core 
topic in pharmacy education and 73.2 % (n = 
306) of the students strongly agreed that it 
should be made as a compulsory duty for 
pharmacists. About 84 % (n = 358) of the 
students believed that information on how to 
report ADRs should be taught to senior 
pharmacy students. Although only 39.6 % (n = 
167) of the students are well prepared to report 
any ADRs in their future practice with their 
current knowledge. Sixty five percent (n = 277) of 
students agreed that they are willing to perform 
ADRs reporting during their clerkship. 
 
Table 1: Demographic characteristic of the study 
sample (N = 434) 
 
Variable N (%) 
 

























University                                                     















Table 2: Assessment of students’ knowledge of pharmacovigilance (PV) concept and policy 
 
Question Correct answer 
N (%) 
1. Have you ever heard about the concept of PV? 173 (39.8) 
2. What is the definition of PV? 106 (24.4) 
3. What is the definition of adverse drug reaction? 271 (62.4) 
4. In Jordan, are there legal provisions in the medicines act that provide for PV activities? 126 (29.0) 
5. In Jordan, is there a PV centre? 102 (23.5) 
6. In Jordan, is there an official standardized form for reporting adverse drug reactions? 194 (44.7) 
7. Do you know from where can you get the ADR reporting form? 166 (38.2) 




9. To whom should you report the ADRs? 197 (45.4%) 
10. It is necessary to confirm that an ADR is related to a particular drug before reporting it 342 (78.8%) 
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Table 3: Factors affecting knowledge of pharmacovigilance and ADR reporting score among pharmacy students 
  











Type of study;  
Pharmacy students (n=274) 





< 0.001 a * 
Level of study;  
Fourth year (n=98) 
Fifth year (n=306) 






< 0.001 b * 
Current university                                                     
1 (public) (n=254)                                                        
2 (private) (n=156) 






< 0.001 b * 







< 0.001 a * 
a: independent sample t-test, b: one way ANOVA , * statistically significant 
 
About 61.2 % (n = 259) of participating students 
agreed that unserious adverse reaction should 
be reported, also 60.4 % (n = 258) of students 
agreed that not only reactions for new products 
should be reported. Around 65.6 % (n = 279) 
supported the statement that serious and 
unexpected reactions that were neither fatal nor 
life-threatening during clinical trials had to be 
reported. Students also agreed that both well-
known reactions and reactions not reported 
previously for a particular drug should be 
reported (45.2 % (n = 191) and 67.8 % (n = 288) 
respectively). 
 
Table 5 shows the perception of students toward 
the importance of reporting ADRs. It is obvious 
that almost the majority of them believed that 















 Pharmacovigilance should be included as a core topic 
in pharmacy education. 
360 (84.9) 53 (12.5) 11 (2.6) 
 ADRs reporting should be made compulsory for 
pharmacists. 
306 (73.2) 81 (19.7) 31 (7.4) 
 I am willing to report ADRs during my clerkship. 277 (65.0) 104 (24.4) 45 (10.6) 
 Information on how to report ADRs should be taught to 
senior pharmacy students. 
358 (84.4) 47 (11.1) 19 (4.5) 
 With my present knowledge, I am very well prepared 
to report any ADRs notice in my future practice. 
167 (39.6) 120 (28.4) 135 (32.0) 
 I believe that unserious adverse reaction should be 
reported. 
259 (61.2) 82 (19.4) 82 (19.4) 
 I believe that only reactions for new products should 
be reported. 
111 (26.0) 58 (13.6) 258 (60.4) 
 I believe serious and unexpected reactions that are not 
fatal or life-threatening during clinical trials must not be 
reported. 
92 (21.6) 54 (12.7) 279 (65.6) 
 Reporting of well known ADRs makes no significant 
contribution to the reporting system. 
153 (36.2) 79 (18.7) 191 (45.2) 
 I believe that there is no need to report adverse 
reaction not reported before for a particular drug. 
 
90 (21.2) 47 (11.1) 288 (67.8) 
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1. To enable safe drugs to be identified. 402 (94.1) 20 (4.7) 5 (1.2) 
2. To measure the incidence of ADRs. 392 (92.0) 30 (7.0) 4 (1.0) 
3. To identify factors that might predispose to an ADR. 386 (91.0) 30 (7.1) 8 (1.9) 
4. To identify previously unrecognized ADRs. 376 (89.1) 35 (8.3) 11 (2.6) 
5. To compare ADRs for drugs in similar therapeutic classes. 358 (83.8) 57 (13.3) 12 (2.8) 
6. To compare ADRs of the same d rug from different drug 
companies. 




Spontaneous reporting of ADRs is an indication 
of pharmacovigilance awareness, because they 
are effective for distinguishing serious 
unexpected ADRs, medication errors, therapeutic 
inefficiency and disagreement in drug quality, 
besides its low cost. Despite the fact that practice 
of pharmacovigilance varies from country to 
country, the pharmacists’ primary responsibility is 
the benevolence of each individual, so they are 
more likely to early detect ADRs than other 
healthcare professionals.  
 
As future pharmacy practitioners, pharmacy 
students need to be well trained on how to 
recognize, prevent, and report ADRs, since the 
involvement of pharmacy students in ADRs 
reporting has led to a significant increase in the 
number of documented ADRs in a previous study 
[14]. Few studies have been carried out to 
evaluate pharmacy students’ knowledge and 
attitudes toward ADRs reporting [14,15]. To the 
best of our knowledge, this is the first study in 
Jordan that evaluates the knowledge and 
perception of BPharm and PharmD students 
toward pharmacovigilance and ADR reporting.  
 
Adverse drug reaction under reporting is a global 
reality evidenced by different recognized studies, 
which were carried out in different countries 
[4,12,15-20]. In these studies, where they found 
that a deficiency in knowledge and perceptions 
about pharmacovigilance and ADRs reporting is 
accountable for ADRs under reporting in both 
developed and developing countries [12,16,18-
20]. In a different study, ignorance and insecurity 
were the main factors attributed to professionals’ 
low knowledge about the activities of analysis of 
drug safety [21]. 
 
Our students’ knowledge score was a little bit 
lower than that reported from pharmacy students 
of Malaysia (mean score 6.9/10) [14] and 
Philippines (mean score 3.52/5) [22]. This can be 
due to the weak media role in promoting the 
awareness about pharmacovigilance and lack of 
workshops and seminars about ADRs reporting 
in the Jordanian universities.   
 
The higher knowledge score among PharmD 
students  compared to BPharm students was due 
to the fact that 51.9 % (n=) of them admitted that 
they have ever attended a workshop of 
pharmacovigilance among their educational 
courses compared to 11.3 % (n = 83) of BPharm 
students, and those students who attended the 
course were from the public university at the fifth 
year level.  
 
Similar to the results from previous studies [4–6], 
a significant proportion of the study participants 
in the present study agreed that the pharmacist 
is one of the most important healthcare 
professionals to report ADRs.  
 
Most of the study students expressed a positive 
attitude toward pharmacovigilance and ADRs 
issues and they agreed that they are willing to 
report ADRs during their clerkship. Attitude is 
conceivably modifiable variable exerting a strong 
influence on ADRs reporting [19], the greater the 
patient attitude the more positive influence on the 
overall ADRs reporting rate. This issue was 
proved previously by Granas et al in which they 
have shown that an educational program can 
significantly modify pharmacists’ reporting-
related attitudes and influence the ADRs 
reporting behaviour in a positive manner [12].  
 
It would be advantageous to educate 
undergraduate pharmacy students about the 
importance of pharmacovigilance and ADRs 
reporting and encourage them to be involved in 
advocating ADRs reporting for both pharmacists 
and other healthcare professionals. By promoting 
a culture for ADRs reporting among healthcare 
professionals, the problem of under reporting 
could be reduced.  
 
Most of students believed that serious and 
unexpected ADRs, including those that are 
neither fatal nor life threatening, must be 
reported. Students also agreed that both well-
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known reactions and reactions not reported 
before for a particular drug should be reported 
(45.2 and 67.8 % respectively) which is 
consistent with the results of previous studies 
involving pharmacists and other healthcare 
professionals [4,6]. 
 
It was also found that the majority of students 
agreed that pharmacovigilance should be 
included as a core topic in pharmacy education. 
This indicated their positive perception of the 
importance of pharmacovigilance. This finding is 
similar to that of previous reports involving 
healthcare professionals [6,12]. To achieve 
better awareness about pharmacovigilance, 
more education and training programs on ADRs 
reporting are required in pharmacy faculties. 
Changhai et al showed that Pharmacists who 
receive more education and training on ADR 
reporting are more likely to report ADRs [7].  
 
Limitation of the study 
 
There are some methodological weaknesses of 
this study since it was conducted among BPharm 
and PharmD students in only three schools of 
pharmacy in Jordan universities who were 
accessible to the researcher. Consequently, the 
findings should not be extrapolated to pharmacy 
students in other universities. It is necessary to 
extend this type of study to other universities in 




The findings of this study underscore the urgent 
need for adjustment in the training curriculum to 
emphasize the role and responsibility of 
pharmacy students in pharmacovigilance 
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